Virax Biolabs Group Limited
Stock Forecast, Prediction & Price Target

Virax Biolabs Group Limited Financial Estimates

Virax Biolabs Group Limited Revenue Estimates

Virax Biolabs Group Limited EBITDA Estimates

Virax Biolabs Group Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2022 3/31/2023 3/31/2024 3/31/2026 3/31/2027
Revenue
 
% change YoY
$0
 
N/A
$8.56K
 
0%
$156.41K
 
1727.11%
Avg: $13.49M
Low: $13.49M
High: $13.49M
avg. 8525.55%
Avg: $13.49M
Low: $13.49M
High: $13.49M
avg. 0%
Net Income
 
% change YoY
$-1.70M
 
N/A
$-5.45M
 
-219.37%
$-6.73M
 
-23.38%
Avg: $425.19K
Low: $425.19K
High: $425.19K
avg. 106.31%
Avg: $0
Low: $0
High: $0
avg. -100%
EBITDA
 
% change YoY
$-1.73M
 
N/A
$-5.44M
 
-213.91%
$-6.60M
 
-21.44%
Avg: $-6.74M
Low: $-6.74M
High: $-6.74M
avg. -2.07%
Avg: $-6.74M
Low: $-6.74M
High: $-6.74M
avg. 0%
EPS
 
% change YoY
-$1.5
 
N/A
-$5.13
 
-242%
-$3.36
 
34.50%
Avg: $0.4
Low: $0.4
High: $0.4
avg. 111.90%
Avg: $0
Low: $0
High: $0
avg. -100%
Operating Expenses
 
% change YoY
$1.73M
 
N/A
$5.73M
 
230.59%
$6.54M
 
14.23%
Avg: $2.13B
Low: $2.13B
High: $2.13B
avg. 32581.63%
Avg: $2.13B
Low: $2.13B
High: $2.13B
avg. 0%

FAQ

What is Virax Biolabs Group Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 53.15% in 2026-2027.

We have gathered data from N/A analysts. Their low estimate is 425.19K, average is 425.19K and high is 425.19K.

What is Virax Biolabs Group Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 4262.77% in 2026-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $13.49M, average is $13.49M and high is $13.49M.

What is Virax Biolabs Group Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 55.95% in 2026-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is $0.4, average is $0.4 and high is $0.4.